Computer-aided drug design to generate a unique antibiotic family
- PMID: 39333560
- PMCID: PMC11436758
- DOI: 10.1038/s41467-024-52797-2
Computer-aided drug design to generate a unique antibiotic family
Abstract
The World Health Organization has identified antibiotic resistance as one of the three greatest threats to human health. The need for antibiotics is a pressing matter that requires immediate attention. Here, computer-aided drug design is used to develop a structurally unique antibiotic family targeting holo-acyl carrier protein synthase (AcpS). AcpS is a highly conserved enzyme essential for bacterial survival that catalyzes the first step in lipid synthesis. To the best of our knowledge, there are no current antibiotics targeting AcpS making this drug development program of high interest. We synthesize a library of > 700 novel compounds targeting AcpS, from which 33 inhibit bacterial growth in vitro at ≤ 2 μg/mL. We demonstrate that compounds from this class have stand-alone activity against a broad spectrum of Gram-positive organisms and synergize with colistin to enable coverage of Gram-negative species. We demonstrate efficacy against clinically relevant multi-drug resistant strains in vitro and in animal models of infection in vivo including a difficult-to-treat ischemic infection exemplified by diabetic foot ulcer infections in humans. This antibiotic family could form the basis for several multi-drug-resistant antimicrobial programs.
© 2024. The Author(s).
Conflict of interest statement
A university spin-out company, DeNovaMed Inc, has been assigned patents related to parts of the work described. C.J.B., F.W., E.L., M.M.T., A.L.R., D.F.W., and C.R.M. have shares in DeNovaMed Inc. The remaining authors declare no competing interests.
Figures


References
-
- Balasegaram, M. & Piddock, L. J. V. The Global Antibiotic Research and Development Partnership (GARDP) not-for-profit model of antibiotic development. ACS Infect. Dis.6, 1295–1298 (2020). - PubMed
-
- Kuehn, B. Evolution of “Nightmare Bacteria”. JAMA319, 2070 (2018). - PubMed
-
- Pendleton, J. N., Gorman, S. P. & Gilmore, B. F. Clinical relevance of the ESKAPE pathogens. Expert Rev. Anti Infect. Ther.11, 297–308 (2013). - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases